James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $568.74 ($5.7M) on 2026-05-14, disclosed to the SEC on 2026-05-15.
Scheduled sale ($5.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $568.74 | 80 | $45K | 0.8% |
| 2 | $570.52 | 80 | $46K | 0.8% |
| 3 | $571.53 | 603 | $345K | 6.0% |
| 4 | $572.78 | 970 | $556K | 9.7% |
| 5 | $574.04 | 2,456 | $1.4M | 24.5% |
| 6 | $574.76 | 3,419 |
| $2.0M |
| 34.2% |
| 7 | $575.78 | 1,712 | $986K | 17.2% |
| 8 | $576.75 | 293 | $169K | 2.9% |
| 9 | $577.93 | 307 | $177K | 3.1% |
| 10 | $578.59 | 80 | $46K | 0.8% |
| Total | $574.47 avg | 10,000 | $5.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |